1. Comprehensive Laboratory, Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
2. Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lund University, S-221 85 Lund, Sweden.
Int J Med Sci. 2014 Feb 20;11(4):365-72. doi: 10.7150/ijms.7696. eCollection 2014.
The present study investigated the correlation among genetic polymorphisms of the proximal promoter region of apolipoprotein M (apoM) gene, the polymorphisms in relation to apoM expressions and the susceptibility to coronary artery diseases (CAD) in a Han Chinese population. Four common polymorphic sites, i.e., T-1628G, C-1065A, T-855C and T-778C, were confirmed, and a new deletion mutation C-724del was found, in 206 CAD patients and 209 non-CAD patients using direct DNA sequencing analyses. Occurrences of alleles T-1628G, T-855C and C-724del were significantly higher in CAD patients compared to non-CAD patients. Moreover we examined all these polymorphisms in relation to apoM expression by applying luciferase reporter assay. It demonstrated that constructs -855C and 724del showed obvious decreased luciferase activities, i.e., (0.93±0.15 vs. 2.11±0.15; P=0.012) and (1.13±0.25 vs. 2.11±0.15; P=0.009) respectively, which indicates these two polymorphisms could confer decreased apoM expressions. Meanwhile the occurrences of these two SNP were also significantly higher in the CAD patients than in non-CAD patients. It is therefore reasonable to speculate that down-regulated apoM expressions in relation to these polymorphisms may affect HDL and cholesterol metabolism in vivo and further influence the susceptibility to CAD, although the underlying mechanisms need further investigation.
本研究旨在探讨载脂蛋白 M (apoM) 基因近端启动子区遗传多态性与 apoM 表达及冠心病易感性的相关性。通过直接 DNA 测序分析,在 206 例冠心病患者和 209 例非冠心病患者中,共证实了 4 个常见的多态性位点,即 T-1628G、C-1065A、T-855C 和 T-778C,以及一个新的缺失突变 C-724del。与非冠心病患者相比,冠心病患者等位基因 T-1628G、T-855C 和 C-724del 的发生率明显升高。此外,我们通过荧光素酶报告基因检测分析了所有这些多态性与 apoM 表达的关系。结果表明,-855C 和 724del 构建体的荧光素酶活性明显降低,分别为(0.93±0.15 比 2.11±0.15; P=0.012)和(1.13±0.25 比 2.11±0.15; P=0.009),提示这两个多态性可能导致 apoM 表达降低。同时,这两个 SNP 在冠心病患者中的发生率也明显高于非冠心病患者。因此,可以合理推测,与这些多态性相关的 apoM 表达下调可能会影响体内 HDL 和胆固醇代谢,进而影响冠心病的易感性,尽管其潜在机制仍需进一步研究。